Ying-Shuan Lailee

Title: Innovations of Ying-Shuan Lailee in Antibody-Drug Conjugates

Introduction

Ying-Shuan Lailee is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions for cancer treatment. His work focuses on antibody-drug conjugates, which are designed to enhance the efficacy of cancer therapies.

Latest Patents

Ying-Shuan Lailee holds a patent for "Antibody-drug conjugates containing an anti-mesothelin antibody and uses thereof." This patent describes an immunoconjugate that includes an antibody with an antigen-binding fragment specifically targeting an epitope in mesothelin. The immunoconjugate comprises a linker connected to an N-glycan, along with two payloads that can be the same or different. Additionally, the patent outlines a pharmaceutical composition that includes the immunoconjugate and a method for treating cancer.

Career Highlights

Ying-Shuan Lailee is associated with the Development Center for Biotechnology, where he has been instrumental in advancing research and development in the field of biopharmaceuticals. His innovative approach to creating targeted therapies has positioned him as a key figure in the biotechnology sector.

Collaborations

Ying-Shuan Lailee has collaborated with notable colleagues, including Shih-Hsien Chuang and Wei-Ting Sun. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic strategies.

Conclusion

Ying-Shuan Lailee's contributions to the field of antibody-drug conjugates represent a significant advancement in cancer treatment. His innovative work continues to inspire future research and development in biotechnology.